Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1043]

ASCO 2010: Radiation therapy on top of hormone therapy inproves survival for locally advanced prostate cancer

ASCO 2010: Radiation therapy on top of hormone therapy inproves survival for locally advanced prostate cancer

EBCC7: Beta-blockers help reduce metastasis and improve survival in patients

EBCC7: Beta-blockers help reduce metastasis and improve survival in patients

EBCC7: Discovery that PARP protein exists in all tumour types will help target chemotherapy and predict response

EBCC7: Discovery that PARP protein exists in all tumour types will help target chemotherapy and predict response

EBCC7: Survival in metastatic breast cancer patients is improving

EBCC7: Survival in metastatic breast cancer patients is improving

EBCC7: Pregnancy for breast cancer survivors: meta-analysis reveals it is safe and could improve survival

EBCC7: Pregnancy for breast cancer survivors: meta-analysis reveals it is safe and could improve survival

Hormone therapy plus radiation improves survival and reduces recurrence in men with intermediate-risk early-stage prostate cancer

Hormone therapy plus radiation improves survival and reduces recurrence in men with intermediate-risk early-stage...

Update on hormonal therapy for metastatic breast cancer

Update on hormonal therapy for metastatic breast cancer

Double fulvestrant dose for oestrogen receptor-positive advanced breast cancer

Double fulvestrant dose for oestrogen receptor-positive advanced breast cancer

SABCS congress news: PEPI developed to identify ER+ breast cancers with poor outcome

SABCS congress news: PEPI developed to identify ER+ breast cancers with poor outcome

SABCS congress news: Two targeted therapies 'better than one' in HER2-positive fight

SABCS congress news: Two targeted therapies 'better than one' in HER2-positive fight

More from ecancer